PLACE Trial: Preserving Long-Acting Contraception Through Education

ConditionContraception
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-49
SponsorPakistan Institute of Medical Sciences

About this trial

Study Overview Summary

This randomized controlled trial will evaluate the effectiveness of structured counseling in improving the continuation rates of long-acting reversible contraception (LARC) among women in Islamabad, Pakistan, who present to family planning clinics for early removal of their contraception devices (copper-T IUD or Jadelle implant). The study, starting December 15, 2025, will recruit women from three federal government-approved clinics.

The trial will randomly assign participants to either an intervention group, where they will receive culturally sensitive counseling to encourage continued use of LARC, or a control group, where contraception will be removed upon client request without counseling. The goal is to determine if structured counseling can increase the likelihood of women continuing their LARC method.

Eligibility criteria

Qualifiers

Women presenting at the clinics exclusively for removal of a copper-T IUD or Jadelle subdermal implant within 2 years of use and within the first 2 months of the study.

Disqualifiers

Women not wishing to participate or unable to provide informed consent.

Trial design

Treatments tested in this trial

  • Structured counseling

Treatment groups

900 Participants
are divided into 2 treatment groups